Keyphrases
Primary Dysmenorrhea
100%
Magnetoencephalography
86%
Menstrual Pain
45%
Brain Activity
35%
Bipolar Disorder
32%
Functional Connectivity
30%
Functional Magnetic Resonance Imaging
29%
Brain Regions
28%
Treatment-resistant Depression
24%
Major Depressive Disorder
22%
Beamformer
20%
Resting State
19%
Visual Artists
19%
International Cooperative Ataxia Rating Scale (ICARS)
19%
Face Recognition System
19%
Visual System
19%
Young Women
18%
Pain Experience
17%
Menstrual Cycle
16%
Antidepressants
16%
Suicidal Ideation
16%
Ketamine
16%
Coarse-to-fine
16%
Brain Magnetic Resonance Imaging
15%
Default Mode Network
15%
Linear Discriminant Analysis
14%
Periovulatory
14%
Visual Creativity
14%
Emotional Processing
13%
Human Brain
13%
Intrinsic Functional Connectivity
13%
Midazolam
13%
Low-dose Ketamine Infusion
13%
Amygdala
13%
Randomized Double-blind
13%
Finger Movement
13%
Small Sample Size Problem
13%
Emotional Faces
13%
Phase-amplitude Coupling
13%
Healthy Side
13%
Modulatory Systems
13%
Side Dominance
13%
Val66Met Polymorphism
13%
OPRM1 A118G
13%
A118G Polymorphism
13%
Dancers
13%
Neural Correlates
13%
Wavelet Basis
12%
Voxel-based Morphometry
11%
Healthy Controls
11%
Neuroscience
Magnetoencephalography
68%
Functional Connectivity
61%
Functional Magnetic Resonance Imaging
40%
Electroencephalogram
34%
Bipolar Disorder
32%
Gyri
28%
Major Depressive Disorder
26%
Default Mode Network
25%
Treatment-Resistant Depression
22%
Neural Network
21%
Behavior (Neuroscience)
21%
Amygdala
20%
Biomechanics
20%
Antidepressant
19%
Ketamine
19%
Brain-Derived Neurotrophic Factor
19%
Independent Component Analysis
19%
Neuroplasticity
19%
Periaqueductal Gray
18%
Magnetic Resonance Imaging
16%
Face
14%
Midazolam
14%
Magnetic Resonance Imaging
14%
Psychogenic Pain
13%
Voxel-Based Morphometry
13%
Inferior Temporal Gyrus
13%
Sensorineural Hearing Loss
13%
Positron Emission Tomography
13%
Cerebellum
12%
Inferior Frontal Gyrus
11%
Alzheimer's Disease
10%
Frontal Lobe
10%
Putamen
10%
Transcranial Magnetic Stimulation
10%
Dynamic Functional Connectivity
9%
Dorsolateral Prefrontal Cortex
9%
Event-Related Potential
9%
Prefrontal Cortex
9%
Positron Emission Tomography
8%
Nociception
8%
Brain Function
8%
Gray Matter
8%
Auditory Cortex
7%
Mild Cognitive Impairment
7%
Alpha Wave
7%
Fluorine-18
7%
Superior Parietal Lobule
6%
CADASIL
6%
Neuroprotective Agent
6%
Treatment of Pain
6%